Rad23 binds ubiquitinated proteins through UBA domains. (A) Protein extracts were prepared from yeast cells that expressed Flag-Rpn10 from the copper-inducible CUP1 promoter (lane 2) or Rad23 from the galactose-inducible GAL1 promoter (lanes 3 and 4, independent preparations). Extracts were also prepared from a wild-type control strain (WT), which did not overexpress either protein (lane 1). Equal amounts of protein were resolved in an SDS-10% polyacrylamide gel, transferred to nitrocellulose (Bio-Rad), and incubated with anti-Ub antibodies (Sigma). The immunoblot (representing the entire SDS-polyacrylamide gel) was developed with enhanced chemiluminescence (NEN/Dupont). (B) GST (lane 1) and GST fusion proteins that expressed full-length Rad23 (lane 2), ΔUbLrad23 (lane 3), and the UbLR23 domain (lane 4) were purified from yeast extracts on glutathione-Sepharose (Amersham/Pharmacia Biotech) and are shown by Coomassie staining. The sizes of the various proteins are indicated at the right. The faint bands that are visible in lane 4 represent proteasome subunits that were coprecipitated with UbLR23. (C) An immunoblot that contained the purified GST fusion proteins in the order described for panel B was incubated with anti-Ub antibodies. The image represents the entire SDS-10% polyacrylamide gel, and the approximate positions of the fusion proteins are indicated. (D) Flag-Rad23 (lane 1) and derivatives that contained defective UBA domains were expressed in yeast and immunoprecipitated (IP) on Flag-agarose (Sigma). The proteins that were bound to the Rad23 proteins were separated by SDS-PAGE, transferred to nitrocellulose, and incubated with antibodies against Ub. Lanes 2 to 6, Flag-rad23uba1, Flag-rad23uba2, Flag-rad23uba1uba2, Flag-ΔUbLrad23, and Flag-rad23Δuba1, respectively. (E) The blot shown in panel D was stripped and incubated with antibodies against Cim5/Rpt1 to examine the interaction between the Rad23 derivatives and the proteasome. The faint band seen in lane 5 reflects a weak cross-reaction against the heavy chain of the anti-Cim5/Rpt1 antibodies, which comigrated with Cim5. (F) A yeast strain expressing Flag-Rad23 was transformed with plasmids expressing Met-β-Gal (M; lane 1), Ub-Pro-β-Gal (Ub-P; lane 2), or Arg-β-Gal (R; lane 3), and protein extracts were incubated with Flag-agarose. The bound proteins were resolved by SDS-PAGE and examined by immunoblotting with antibodies against β-Gal. Lane 4, yeast extract that contained Flag-Rad23, but none of the β-Gal proteins (control). Bracket, positions of the β-Gal proteins that were copurified with Flag-Rad23; ∗, nonspecific reaction against cellular protein; H, electrophoretic positions of the heavy chain of the anti-β-Gal antibodies. (G) Human hHR23-B was expressed in yeast cells as a fusion to GST and purified on glutathione-Sepharose (lane 1). Lane 2, extracts from a yeast strain that expressed GST. The bound proteins were resolved in a 10% polyacrylamide gel, and an immunoblot was incubated with antibodies against Ub. The image represents the entire SDS-10% polyacrylamide gel.